Stock Market Today: Growth Takes a Backseat to Value Yet Again
A violent rotation from tech and other growth stocks, and into value names, continued Tuesday as a COVID drug received an emergency-use green light.
A rotation away from growth and into value continued apace Tuesday amid more news on the COVID front.
Less than 24 hours after Pfizer (PFE, -1.3%) and BioNTech (BNTX, +7.6%) released promising trial data for their vaccine candidate, the U.S. Food and Drug Administration approved Eli Lilly's (LLY, +3.0%) antibody treatment on an emergency-use basis.
"Yesterday after market close, LLY announced that its monoclonal antibody treatment (LY-CoV555) received FDA Emergency Use Authorization (EUA) based on positive findings from the BLAZE-1 Phase 2 studies to treat patients with mild to moderate Covid-19 cases after immediate diagnosis," writes CFRA analyst Sel Hardy (Buy). "As daily new Covid-19 infections and hospitalizations reach unprecedented highs, we think the EUA opens a considerable market opportunity for LLY," adding that AmerisourceBergen (ABC, +3.7%) will be in charge of U.S. delivery.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
That continued a trend of investors moving money from heavily bought growth stocks to battered cyclical plays.
The Dow Jones Industrial Average climbed 0.9% on Tuesday, to another new high of 29,420, led by the likes of Walgreens (WBA, +6.5%) and Boeing (BA, +5.2%), the latter rising amid reports that the government regulators are nearly finished with their review of proposed changes to the troubled 737-MAX aircraft. But the Nasdaq Composite suffered another big drop, losing 1.4% to 11,553.
Other action in the stock market today:
- The S&P 500 slipped by 0.1% to 3,545.
- Small caps had a day, as the Russell 2000 gained 1.9% to a fresh high of 1,737.
- Gold futures improved by 1.2%, settling at $1,876.40 per ounce.
- U.S. crude oil futures also settled higher, improving 2.9% to $43.61 per barrel.
Several Trends Could Be Here to Stay, However
A team of UBS strategists believe the rotation has more room to run: "After Monday's (and last week's) strong moves, we find that … US Growth stocks are pricing in the most hope of normalization, while European and US Value stocks are pricing in the least, and therefore should have more upside potential," they write.
But don't expect the coming months and 2021 to completely flip the script.
We could also see a continuation of several trends that blossomed over the past few months. For instance, the earnings calendar included a big win from D.R. Horton (DHI, +9.1), which reported a quarterly profit beat and raised its dividend, putting more fuel behind 2020's rally in housing-market stocks. A second-half resurgence in initial public offerings (IPOs) should remain strong, thanks to several big-name offerings expected to go live by the end of this year and throughout 2021.
And we could see continued outperformance by one of the market's most ignored sectors: materials stocks.
While metals miners and chemical producers don't tell scintillating stories, they've got what counts: an improving macroeconomic picture, often low valuations and, in some cases, decent dividend programs. While they've also been outperforming for several months now, the "great rotation" should still benefit many of these value-priced materials stocks.
Kyle Woodley was long BA as of this writing.
-
How to Plan a (Successful) Family ReunionFrom shaping the guest list to building the budget, here's how to design a successful and memorable family reunion.
-
These Unloved Energy Stocks Are a BargainCleaned-up balance sheets and generous dividends make these dirt-cheap energy shares worth a look.
-
You've Heard It Before, But This Investment Advice Still Pays Off"Time in the market beats timing the market" ¬— been there, done that, right? But don't write off the underlying advice. There's a reason it's a popular saying.
-
Stocks Struggle for Gains to Start 2026: Stock Market TodayIt's not quite the end of the world as we know it, but Warren Buffett is no longer the CEO of Berkshire Hathaway.
-
If You'd Put $1,000 Into Lowe's Stock 20 Years Ago, Here's What You'd Have TodayLowe's stock has delivered disappointing returns recently, but it's been a great holding for truly patient investors.
-
If You'd Put $1,000 Into 3M Stock 20 Years Ago, Here's What You'd Have TodayMMM stock has been a pit of despair for truly long-term shareholders.
-
'Humbug!' Say Consumers, Despite Hot GDP: Stock Market Today"The stock market is not the economy," they say, but both things are up. Yet one survey says people are still feeling down in the middle of this complex season.
-
Stocks Chop as the Unemployment Rate Jumps: Stock Market TodayNovember job growth was stronger than expected, but sharp losses in October and a rising unemployment rate are worrying market participants.
-
Stocks Struggle Ahead of November Jobs Report: Stock Market TodayOracle and Broadcom continued to fall, while market participants looked ahead to Tuesday's jobs report.
-
AI Stocks Lead Nasdaq's 398-Point Nosedive: Stock Market TodayThe major stock market indexes do not yet reflect the bullish tendencies of sector rotation and broadening participation.
-
Stocks Bounce Back With Tech-Led Gains: Stock Market TodayEarnings and guidance from tech stocks and an old-school industrial lifted all three main U.S. equity indexes back into positive territory.
